COGT - Cogent Biosciences Inc
This page shows which of the focused investors we track hold COGT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2025 it was held by 2 managers with an aggregate reported value of $87.65M, which is 0.01% of the combined portfolio.
As of Q4 2025, 2 tracked institutional managers held COGT (Cogent Biosciences Inc) with an aggregate reported value of $87.65M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades COGT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2025
- Ticker
- COGT
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 1.86% | Add +109.0% | 2,214,470 | $78.66M |
Other instruments
Bonds, warrants, or other non-share-class principal positions in COGT.
| 1 | Howard Marks - Oaktree Capital Management | New | 7,650,000 | $8.99M |
Loading holder history for COGT…